Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Burke

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Annals of Internal Medicine|June 16, 2010
Systematic review: factors associated with risk for and possible prevention of cognitive decline in later lifeBrenda L Plassman, John W Williams, James R Burke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathwaysJinming Yang, Katayoun I Amiri, James R Burke, et al.
Neuroscience Letters|April 18, 2002
Expanded polyglutamine stretches form an 'aggresome'Takayoshi Shimohata, Aki Sato, James R Burke, et al.
Assay and Drug Development Technologies|October 18, 2007
Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assayLora Hamuro, Guangtao Zhang, Timothy J Tucker, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2008
Job demands and dementia risk among male twin pairsGuy G Potter, Michael J Helms, James R Burke, et al.
International Psychogeriatrics|August 17, 2011
An international perspective on advanced neuroimaging: cometh the hour or ivory tower?Craig W Ritchie, David Ames, James R Burke, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 19, 2013
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseasesH Akiko Popiel, Toshihide Takeuchi, James R Burke, et al.
Journal of the American Geriatrics Society|June 1, 2012
Screening for cognitive impairment: comparing the performance of four instruments in primary careTracey Holsinger, Brenda L Plassman, Karen M Stechuchak, et al.
Journal of the American Geriatrics Society|June 3, 2015
Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care PopulationTracey Holsinger, Brenda L Plassman, Karen M Stechuchak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2008
Midlife activity predicts risk of dementia in older male twin pairsMichelle C Carlson, Michael J Helms, David C Steffens, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|June 16, 2010
Systematic review: factors associated with risk for and possible prevention of cognitive decline in later lifeBrenda L Plassman, John W Williams, James R Burke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathwaysJinming Yang, Katayoun I Amiri, James R Burke, et al.
Neuroscience Letters|April 18, 2002
Expanded polyglutamine stretches form an 'aggresome'Takayoshi Shimohata, Aki Sato, James R Burke, et al.
Assay and Drug Development Technologies|October 18, 2007
Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assayLora Hamuro, Guangtao Zhang, Timothy J Tucker, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2008
Job demands and dementia risk among male twin pairsGuy G Potter, Michael J Helms, James R Burke, et al.
International Psychogeriatrics|August 17, 2011
An international perspective on advanced neuroimaging: cometh the hour or ivory tower?Craig W Ritchie, David Ames, James R Burke, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 19, 2013
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseasesH Akiko Popiel, Toshihide Takeuchi, James R Burke, et al.
Journal of the American Geriatrics Society|June 1, 2012
Screening for cognitive impairment: comparing the performance of four instruments in primary careTracey Holsinger, Brenda L Plassman, Karen M Stechuchak, et al.
Journal of the American Geriatrics Society|June 3, 2015
Stability of Diagnoses of Cognitive Impairment, Not Dementia in a Veterans Affairs Primary Care PopulationTracey Holsinger, Brenda L Plassman, Karen M Stechuchak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2008
Midlife activity predicts risk of dementia in older male twin pairsMichelle C Carlson, Michael J Helms, David C Steffens, et al.
Pageof 13